Display options
Share it on

Lab Anim Res. 2017 Mar;33(1):15-23. doi: 10.5625/lar.2017.33.1.15. Epub 2017 Mar 27.

The effects of pentoxifylline adminstration on fracture healing in a postmenopausal osteoporotic rat model.

Laboratory animal research

Mohammad Mahdi Vashghani Farahani, Reza Ahadi, Mohammadamin Abdollahifar, Mohammad Bayat

Affiliations

  1. Basic Sciences Department, Paramedical School, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  2. Department of Anatomy, School of medicine, Iran University of Medical Sciences, Tehran, Iran.
  3. Department of Anatomical sciences and Biology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  4. Cellular and Molecular Biology Research Centre, Department of Anatomical Sciences and Biology, Medical School, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

PMID: 28400835 PMCID: PMC5385278 DOI: 10.5625/lar.2017.33.1.15

Abstract

Previous studies report positive effects of pentoxifylline (PTX) alone or in combination with other drugs on some pathologic bone diseases as well as an ability to accelerate osteogensis and fracture healing in both animal models and human patients. The aim of this present study was to evaluate the effects of PTX administration on Hounsfield unit and bone strength at catabolic response (bone resorbing) of a fracture in an experimental rat model of ovariectomy induced osteoporosis (OVX-D). Thirty adult female rats were divided into groups as follows: 1 (OVX, control, no treatment); 2 (OVX, sham: daily distilled water); 3 (OVX, daily alendronate: 3 mg/kg); 4 (OVX, twice daily 100 mg/kg PTX) and 5 (OVX, PTX+alenderonate). OVX was induced by bilateral ovariectomy in all rats. A complete standardized osteotomy of the right femur was made after 3.5 months. PTX and alendronate treatments were performed for eight weeks. Then, rats were euthanized and had its right femur subjected to computerized tomography scanning for measuring Hounsfield unit; eventually, the samples were sent for a three point bending test for evaluation of the bone strength. Administration of PTX with 200 mg/kg and alendronate alone and in combination showed no significant alteration in Hounsfield unit and biomechanical properties of repairing callus of the complete osteotomy compared with the control group. Results showed increased bending stiffness and stress high load mean values of repairing complete osteotomy in PTX-treated rats compared to the control OVX-D.

Keywords: Osteoporosis; femur; hounsfield unit biomechanical phenomena; osteotomy; ovariectomy; rat

Conflict of interest statement

Conflict of interests: The authors declare that there is no financial conflict of interests to publish these results.

References

  1. Endocr Rev. 2000 Apr;21(2):115-37 - PubMed
  2. Bone. 2000 Dec;27(6):811-7 - PubMed
  3. Endocrinology. 2001 Nov;142(11):4673-82 - PubMed
  4. J Bone Miner Res. 2002 Feb;17(2):249-56 - PubMed
  5. Osteoporos Int. 2003;14 Suppl 3:S13-8 - PubMed
  6. Radiat Med. 2003 Sep-Oct;21(5):223-7 - PubMed
  7. Therapie. 2003 Sep-Oct;58(5):403-7 - PubMed
  8. J Bone Miner Metab. 2004;22(4):329-34 - PubMed
  9. FEBS Lett. 2005 Jan 31;579(3):832-8 - PubMed
  10. Photomed Laser Surg. 2006 Apr;24(2):202-6 - PubMed
  11. Med Sci Monit. 2006 Jun;12(6):BR201-7 - PubMed
  12. J Womens Health (Larchmt). 2006 Jul-Aug;15(6):709-19 - PubMed
  13. Osteoporos Int. 2006 Dec;17(12):1726-33 - PubMed
  14. J Bone Joint Surg Br. 2007 Apr;89(4):425-33 - PubMed
  15. Eur J Pain. 2009 Mar;13(3):253-62 - PubMed
  16. Clin Orthop Relat Res. 2008 Oct;466(10):2306-16 - PubMed
  17. Am J Med. 2009 Feb;122(2 Suppl):S14-21 - PubMed
  18. Calcif Tissue Int. 2010 Jan;86(1):23-32 - PubMed
  19. Br J Oral Maxillofac Surg. 2012 Jan;50(1):41-4 - PubMed
  20. Proc Natl Acad Sci U S A. 1990 Jan;87(2):533-7 - PubMed
  21. Mt Sinai J Med. 2011 May-Jun;78(3):327-41 - PubMed
  22. Nat Rev Rheumatol. 2011 Sep 20;7(11):631-8 - PubMed
  23. Eklem Hastalik Cerrahisi. 2011 Dec;22(3):160-5 - PubMed
  24. Lab Anim Res. 2012 Sep;28(3):209-15 - PubMed
  25. Eur J Pharmacol. 2013 Jan 30;700(1-3):165-72 - PubMed
  26. Clin Interv Aging. 2013;8:681-8 - PubMed
  27. J Gerontol A Biol Sci Med Sci. 2014 Mar;69(3):346-53 - PubMed
  28. Curr Drug Targets. 2013 Dec;14(13):1524-32 - PubMed
  29. J Oral Maxillofac Surg. 2014 Feb;72(2):334-7 - PubMed
  30. Life Sci. 2013 Sep 17;93(9-11):423-8 - PubMed
  31. Drug Deliv. 2015 Dec;22(8):1094-1102 - PubMed
  32. Spine (Phila Pa 1976). 2014 May 15;39(11):E676-E683 - PubMed
  33. J Am Assoc Lab Anim Sci. 2014 Mar;53(2):185-92 - PubMed
  34. Iran Red Crescent Med J. 2015 Mar 31;17(3):e19389 - PubMed
  35. Yonsei Med J. 2015 Jul;56(4):1106-13 - PubMed
  36. J Invest Surg. 2015;28(4):196-201 - PubMed
  37. Oral Maxillofac Surg. 2016 Mar;20(1):97-101 - PubMed
  38. Drug Des Devel Ther. 2015 Sep 09;9:5195-201 - PubMed
  39. Acta Orthop Traumatol Turc. 2015;49(6):676-82 - PubMed
  40. Iran Red Crescent Med J. 2015 Dec 28;17(12):e29513 - PubMed
  41. J Clin Diagn Res. 2015 Dec;9(12):ZE01-4 - PubMed
  42. PLoS One. 2016 May 05;11(5):e0154926 - PubMed
  43. Photomed Laser Surg. 2017 Oct;35(10):520-529 - PubMed
  44. J Med. 1984;15(4):319-22 - PubMed
  45. Biochem J. 1981 Jun 1;195(3):645-52 - PubMed
  46. J Med. 1983;14(2):137-45 - PubMed
  47. J Bone Miner Res. 1994 Sep;9(9):1407-17 - PubMed
  48. J Bone Miner Res. 1994 Jun;9(6):883-90 - PubMed
  49. Endocrinology. 1993 Feb;132(2):823-31 - PubMed
  50. J Bone Miner Res. 1997 Feb;12(2):172-8 - PubMed
  51. J Bone Miner Res. 1997 Jan;12(1):24-35 - PubMed
  52. Lasers Surg Med. 1998;22(2):97-102 - PubMed

Publication Types